| Financial Year |
March 31 2023 |
| Monetary Funds |
142,992,750.49 |
| Held-for-trading Financial Assets |
55,106.24 |
| Notes Receivable |
131,155,721.51 |
| Accounts Receivable |
602,612,313.01 |
| Advances to Suppliers |
38,931,883.75 |
| Other Receivables |
65,349,455.59 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
22,436,980.32 |
| Inventories |
507,634,706.79 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
87,903,714.93 |
| Total Current Assets |
1,700,580,341.88 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
336,381,000.47 |
| Investment Properties |
-- |
| Fixed Assetes |
3,835,534,680.01 |
| Under-construction Projects |
1,631,684,465.11 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
628,345.31 |
| Oil and Gas Assets |
-- |
| Intangible Assets |
951,919,062.36 |
| R&D expenses |
409,338,116.85 |
| Goodwill |
199,720,237.13 |
| Long-Term Deferred and Prepaid Expenses |
37,149,845.88 |
| Deferred Income Tax Assets |
26,367,156.96 |
| Other Non-Current Assets |
29,477,794.43 |
| Sub-Total of Non-Current Assets |
7,619,900,314.07 |
| Total Assets |
9,320,480,655.95 |
| Short-Term Loans |
1,978,190,652.97 |
| Trading Financial liabilities |
-- |
| Notes Payable |
12,207,988.76 |
| Accounts Payable |
848,594,550.60 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
36,468,393.01 |
| Taxes Payable |
34,504,381.32 |
| Interest Payable |
-- |
| Dividend Payable |
7,666,840.00 |
| Other payables |
2,518,432,066.21 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
78,922,444.29 |
| Other Current Liabilities |
90,024,415.85 |
| Sub-Total of Current Liabilities |
5,805,332,198.05 |
| Long-term Loans |
426,680,976.50 |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
129,529,194.72 |
| Special Payable |
-- |
| Estimatied Liabilities |
51,286,333.34 |
| Deferred Income Tax Liabilities |
-- |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
693,067,575.35 |
| Total Liabilities |
6,498,399,773.40 |
| Paid-In Capital(Or Share Stock) |
661,279,045.00 |
| Capital Surplus |
2,152,290,476.39 |
| Surplus Reserve |
105,373,822.86 |
| LESS:Treasury Stock |
8,500,866.64 |
| Undistributed Profits |
-495,579,610.22 |
| Minority Stockholder's Interest |
416,793,641.81 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
2,405,287,240.74 |
| Owner's Equity（Stockholder's Equity） |
2,822,080,882.55 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
9,320,480,655.95 |
